{"schema_version":"secwatch.filing_event.v1","accession":"0000849146-24-000074","form_type":"8-K","ticker":"LFVN","cik":"0000849146","company_name":"Lifevantage Corp","filed_at":"2024-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.040530+00:00","generated_at":"2026-05-31T07:19:08.128243+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"LifeVantage Q4 rev down 9.8% to $48.9M; FY adj EPS $0.59; FY25 guidance $200-210M","bullets":["Q4 GAAP EPS $0.10; adjusted EPS $0.14; revenue down 9.8% YoY to $48.9M.","FY2024 revenue $200.2M (-6.2%); adj EBITDA $17.0M (+44.7%); GAAP EPS $0.23 vs $0.20.","Declared $0.04 dividend payable Sep 17, record Sep 9; cash $16.9M, no debt.","FY2025 guidance: rev $200-210M, adj EBITDA $18-21M, adj EPS $0.70-0.80.","Americas rev -4.1%; Asia/Pacific & Europe -25.2% in Q4, impacted by forex."],"urls":{"canonical":"https://secwatch.observer/filing/0000849146-24-000074","json":"https://secwatch.observer/filing/0000849146-24-000074.json","markdown":"https://secwatch.observer/filing/0000849146-24-000074.md","text":"https://secwatch.observer/filing/0000849146-24-000074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/849146/000084914624000074/0000849146-24-000074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/849146/000084914624000074/lfvn-20240828.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:19:08.128243+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}